ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Quality Indicators"

  • Abstract Number: 0640 • ACR Convergence 2021

    Implementation of Digital Prompt in Electronic Medical Records Improves Pneumonia Vaccination Rates in Patients Prescribed TNF-Inhibitors

    Manjeet Bhamra1 and Andras Perl2, 1SUNY Upstate Medical University, Syracuse, NY, 2State University of New York, Syracuse, NY

    Background/Purpose: Tumor necrosis factor α inhibitors (TNFi) predispose to bacterial infections including pneumonia. In turn, vaccination with pneumococcal 13 valent (PCV13) and pneumococcal 23 valent…
  • Abstract Number: 0644 • ACR Convergence 2021

    Follow-up Scheduling Appears Essential for Success of Rheumatology High Blood Pressure Protocol Across Health Systems

    Christie Bartels, Bret Hanlon, Monica Messina, Sancia Ferguson and Edmond Ramly, University of Wisconsin School of Medicine and Public Health, Madison, WI

    Background/Purpose: To address high blood pressure (BP), target of two ACR quality measures and the leading modifiable risk factor for cardiovascular disease, we previously developed…
  • Abstract Number: 0737 • ACR Convergence 2021

    Enhanced Arthrocentesis of the Flexed Knee with Pneumatic Compression

    Sumir Brahmbhatt1, Ahsan Iqbal1, Fatemeh Farshami2, Maheswari Muruganandam3, Jaren Trost4, David Cisneros5, Adnan Kiani3, N. Suzanne Emil3, Sharon Nunez1, William Hayward6, Philip Band7 and Wilmer Sibbitt3, 1UNM, Albuquerque, NM, 2University of New Mexico, Albuquerque, MD, 3University of New Mexico, Albuquerque, NM, 4Optum, Albuquerque, NM, 5University of New Mexico School of Medicine, Albuquerque, NM, 6New Mexico Highlands University, Las Vegas, NM, 7NYU SOM, New York, NY

    Background/Purpose: To explore an alternative to standard extended knee arthrocentesis using pneumatic compression of the flexed knee.Methods: Using a paired sample design, 41 consecutive effusive…
  • Abstract Number: 1180 • ACR Convergence 2021

    Better Websites, Better Match: Assessing Quality of Rheumatology Fellowship Websites

    Hiral Patel1, D. Benjamin Riffe1 and Rachel Wolfe2, 1Wake Forest School of Medicine, Winston Salem, NC, 2Wake Forest Baptist Health, Winston-Salem, NC

    Background/Purpose: The internet has become an indispensable tool for residency and fellowship recruitment. Prospective applicants rely on publicly available information to learn about the application…
  • Abstract Number: 1895 • ACR Convergence 2021

    Achievement of Target Serum Uric Acid Among Gout Patients Treated with Long-term Urate Lowering Therapy in the ACR’s Rheumatology Informatics System for Effectiveness (RISE) Registry

    Nevin Hammam, Jing Li, Julia L Kay, Jinoos Yazdany and Gabriela Schmajuk, University of California San Francisco, San Francisco, CA

    Background/Purpose: The American College of Rheumatology’s (ACR) 2012 guidelines for the management of gout recommend using a treat-to-target (T2T) approach to lower serum uric acid…
  • Abstract Number: 1696 • ACR Convergence 2020

    Measuring Quality Improvement from CME Participants: Results from the RAPID® CME Initiative

    Stephen Bender1, Michael Weinblatt2 and Daniel Duch1, 1FACTORx, Cherry Hill, NJ, 2Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Medical claims data have been used since 2008 to measure the implementation of the diagnostic and referral strategies resulting from participation in RAPID® CME…
  • Abstract Number: 1779 • ACR Convergence 2020

    Gap in Contraceptive Education to Females with Rheumatic Disease on Teratogenic Medications

    Andras Perl1, Sundus Mian1 and Jihad Ben Gabr1, 1SUNY Upstate Medical University, Syracuse, NY

    Background/Purpose: Teratogenic disease-modifying anti-rheumatic disease modifying drugs (DMARDs) are often prescribed to women of childbearing age. Contraception represents an important area of reproductive health for female patients with…
  • Abstract Number: 1986 • ACR Convergence 2020

    Determinants of Variation in Pediatric Systemic Lupus Erythematosus Care Delivery

    Jon Burnham1, Rosemary Peterson1, Joy Ukaigwe1, Lynsey Cecere1, Andrea Knight2 and Joyce Chang1, 1Children's Hospital of Philadelphia, Philadelphia, PA, 2Division of Rheumatology, The Hospital for Sick Children and Department of Paediatrics, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Patients with pediatric systemic lupus erythematosus (pSLE) receive only a fraction of recommended care.  Moreover, variation in care delivery likely contributes to pervasive racial…
  • Abstract Number: 0111 • ACR Convergence 2020

    Assessment and Treatment of Glucocorticoid-Induced Osteoporosis in a Rheumatology Clinic

    Amanda Stefl1, Shikha Singla2, Jessica Michaud1, Kama Thomas2, Lisa Rein2 and Mary Ellen Csuka2, 1Froedtert Hospital, Milwaukee, WI, 2Medical College of Wisconsin, Milwaukee, WI

    Background/Purpose: Glucocorticoids (GC) are used as a long-term treatment option for an estimated 1% of the US population. The American College of Rheumatology has maintained…
  • Abstract Number: 0167 • ACR Convergence 2020

    Rheumatoid Arthritis Patient Phenotypes from a Digital Health Coaching Engagement Program

    Jonathan Patterson1, Kirby Magid2, Dhiren Patel3 and Matt Allison3, 1Pack Health, Birmingham, AL, 2University of North Carolina at Charlotte, Charlotte, 3Pack Health, Birmingham

    Background/Purpose: The goal of this study was to examine whether cluster analysis could be used to identify homogeneous subgroups of engagement in RA patients enrolled…
  • Abstract Number: 0260 • ACR Convergence 2020

    Does Higher Quality of Care in SLE Improve Quality of Life?

    Shilpa Arora1, Patricia Katz2, Jinoos Yazdany3, Joel Block1, Edward Yelin4 and Meenakshi Jolly5, 1Rush University Medical Center, Chicago, IL, 2University of California, San Francisco, Novato, CA, 3University of California, San Francisco, San Francisco, CA, 4UCSF, San Francisco, CA, 5Rush University, Chicago, IL

    Background/Purpose: Disease activity, damage and quality of life (QOL) are core outcomes in Systemic lupus erythematosus (SLE). ER visits and hospital admissions (non-routine health care…
  • Abstract Number: 0574 • ACR Convergence 2020

    Is Hydroxychloroquine Use a Proxy for Health Care Access? Predictors of First Dispensing Among Medicaid Beneficiaries with Incident Lupus

    Katherine Pryor1, Chang Xu1, Jamie Collins1, Karen Costenbader2 and Candace Feldman1, 1Brigham and Women's Hospital, Boston, 2Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Hydroxychloroquine/chloroquine (HCQ/CQ) is considered to be the backbone of systemic lupus erythematosus (SLE) care. Differences in receipt of HCQ/CQ may exacerbate disparities in adverse…
  • Abstract Number: 0603 • ACR Convergence 2020

    Multisite Study of the Impact of COVID-19 Era Telemedicine Expansion on Reduction in No-Show Rates

    Christie Bartels1, David Gazeley2, Ann Rosenthal3, Sancia Ferguson4, Edmond Ramly5, Monica Messina6 and Douglas White7, 1University of Wisconsin School of Medicine and Public Health, Department of Medicine, Division of Rheumatology, Madison, WI, 2Medical College of Wisconsin, Wauwatosa, WI, 3Medical College of Wisconsin, Milwaukee, WI, 4University of Wisconsin-Madison School of Medicine and Public Health, Department of Medicine, Division of Rheumatology, Oakland, CA, 5University of Wisconsin School of Medicine and Public Health, Department of Family Medicine and Community Health;, Madison, 6University of Wisconsin School of Medicine and Public Health, Department of Medicine, Rheumatology Division, Madison, WI, 7Gundersen Health System, Onalaska, WI

    Background/Purpose: The COVID-19 pandemic led to rapid expansion of telemedicine in all fields, including rheumatology. We hypothesized that increased use of telemedicine would reduce no-show…
  • Abstract Number: 1586 • ACR Convergence 2020

    Rheum Service: Comprehensive Virtual Care During COVID-19

    Stephanie Gottheil1 and Joseph Carson1, 1London Rheumatology, London, ON, Canada

    Background/Purpose: During COVID-19, patients require timely access to rheumatologists while adhering to physical distancing guidelines. In this quality improvement project, we developed a comprehensive virtual…
  • Abstract Number: 1588 • ACR Convergence 2020

    A Quality Improvement Project to Improve Bone Densitometry Ordering in Adult Patients on Chronic Glucocorticoids

    Katherine Kaufman1, Philip Chu1, Mithu Maheswaranathan1, Andrew Johannemann1, D Ryan Anderson1, Isaac Smith1, Akrithi Udupa1, Mary Buckley1, Laura Cannon1, Rachel Randell1 and David Leverenz1, 1Duke University, DURHAM, NC

    Background/Purpose: The 2017 ACR guideline for glucocorticoid-induced osteoporosis (GIOP) recommends DXA testing in patients aged ≥40 years on chronic glucocorticoids. We performed a quality improvement…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology